Cargando…

Meta-analysis: combination of meropenem vs ceftazidime and amikacin for empirical treatment of cancer patients with febrile neutropenia

BACKGROUND: Meropenem monotherapy vs ceftazidime plus amikacin have been approved for use against febrile neutropenia. To assess the effectiveness and safety of them for empirical treatment of cancer patients with febrile neutropenia, we conducted a meta-analysis of randomized controlled trial. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ying, Du, Zhichao, Chen, Yongdong, Liu, Yugang, Yang, Zhitang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	4800
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909104/ https://www.ncbi.nlm.nih.gov/pubmed/33663117 http://dx.doi.org/10.1097/MD.0000000000024883

Ejemplares similares

Comparing the Efficacy of Ceftazidime and Meropenem in Treatment of Febrile Neutropenia in Pediatric Patients with Cancer
por: Ferdosian, F, et al.
Publicado: (2013)

Prevalence of Resistant Gram-Negative Bacilli in Bloodstream Infection in Febrile Neutropenia Patients Undergoing Hematopoietic Stem Cell Transplantation: A Single Center Retrospective Cohort Study
por: Wang, Ling, et al.
Publicado: (2015)

Effect of Combination Therapy of Ceftazidime/Amikacin and Monotherapy with Imipenem on the Treatment of Fever and Neutropenia in Patients with Cancers
por: Anoshirvani, Ali Arash, et al.
Publicado: (2018)

Parvovirus B19 infection presenting with neutropenia and thrombocytopenia: Three case reports
por: Shin, Hyoshim, et al.
Publicado: (2019)

A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients
por: Kamonrattana, Ruchirek, et al.
Publicado: (2019)

Prescribing Empiric Antibiotics for Febrile Neutropenia: Compliance with Institutional Febrile Neutropenia Guidelines
por: Naeem, Doaa, et al.
Publicado: (2018)

374 Indication-based Antimicrobial Derestriction: Ceftazidime Derestriction for Febrile Neutropenia
por: Nash, Colleen B., et al.
Publicado: (2014)

Neutropenia following intravenous immunoglobulin therapy in adult patients with immune thrombocytopenic purpura: A single center experience and literature review
por: Oh, Sang-Bo, et al.
Publicado: (2020)

De-escalation empirical antibiotic therapy improved survival for patients with severe aplastic anemia treated with antithymocyte globulin
por: Fu, Rong, et al.
Publicado: (2017)

Evaluating the efficacy of inhaled amikacin as an adjunct to intravenous combination therapy (ceftazidime and amikacin) in pediatric cystic fibrosis pulmonary exacerbation
por: Rakhshan, Amin, et al.
Publicado: (2023)

Once-a-Day Ceftriaxone–Amikacin Combination as Empiric Antibiotic Therapy to Enable Outpatient Management of Febrile Neutropenia in Children—16-Year Experience from a Single Institute
por: Kanvinde, Shailesh, et al.
Publicado: (2022)

Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin
por: Chen, Kuan-Jen, et al.
Publicado: (2021)

Erythropoietin combined with traditional Chinese medicine for chemotherapy-induced anemias: A protocol of systematic review and meta-analysis
por: Wang, Long-Feng, et al.
Publicado: (2020)

Consensus on diagnosis and empiric antibiotic therapy of febrile neutropenia
por: Giurici, Nagua, et al.
Publicado: (2011)

The efficacy and safety of daunorubicin versus idarubicin combined with cytarabine for induction therapy in acute myeloid leukemia: A meta-analysis of randomized clinical trials
por: Wang, Hanyu, et al.
Publicado: (2020)

Cost-utility of new film-coated tablet formulation of deferasirox vs deferoxamine among major beta-thalassemia patients in Iran
por: Saiyarsarai, Parisa, et al.
Publicado: (2020)

Morphological and Bactericidal Effects of Amikacin, Meropenem and Imipenem on Pseudomonas aeruginosa
por: Moghoofei, Mohsen, et al.
Publicado: (2015)

Combination of low-dose rituximab, bortezomib and dexamethasone for the treatment of autoimmune hemolytic anemia
por: Yao, Mingkang, et al.
Publicado: (2022)

Propranolol restores susceptibility of XDR Gram-negative pathogens to meropenem and Meropenem combination has been evaluated with either tigecycline or amikacin
por: Mabrouk, Samar S., et al.
Publicado: (2023)

Prognostic and Clinicopathological Value of Survivin in Diffuse Large B-cell Lymphoma: A Meta-Analysis
por: Zhang, Ya, et al.
Publicado: (2015)

Evaluating the Use of Meropenem in Hematologic Patients with Febrile Neutropenia: A Retrospective Observational Single-Cohort Study
por: Stuurman, R.A., et al.
Publicado: (2023)

Feasibility of therapeutic plasma exchange-based combination therapy in the treatment of acquired hemophilia A: A retrospective 6 case series
por: Wang, Lin-Yue, et al.
Publicado: (2021)

TKIs combined with chemotherapy followed by allo-HSCT in Philadelphia chromosome-positive myelodysplastic syndrome: A case report and literature review
por: Qi, Shasha, et al.
Publicado: (2022)

Evaluation of astragaloside IV in hepatic fibrosis: A meta-analysis
por: Han, Zhongying, et al.
Publicado: (2021)

The role of thromboelastography in predicting hemorrhage risk in patients with leukemia
por: Bao, Hang-xing, et al.
Publicado: (2018)

Synergetic Effects of Combined Treatment of Colistin With Meropenem or Amikacin on Carbapenem-Resistant Klebsiella pneumoniae in vitro
por: Yu, Lan, et al.
Publicado: (2019)

Interleukin-6 gene-174 G/C promoter polymorphism is not associated with multiple myeloma susceptibility: evidence from meta-analysis: A systematic review and meta-analysis
por: Dong, Xiaohui, et al.
Publicado: (2021)

Treatment of multicentric Castleman disease through combination of tocilizumab, lenalidomide and glucocorticoids: Case report
por: Cai, Sisi, et al.
Publicado: (2019)

A Systematic Review and Meta-Analysis of the Clinical Appropriateness of Blood Transfusion in China
por: Zhu, Changtai, et al.
Publicado: (2015)

Nicotinic acid and related compounds: A meta-analysis of their use for hyperphosphatemia in dialysis patients
por: Liu, Xianhua, et al.
Publicado: (2018)

Model-based meta-analysis of progression-free survival in non-Hodgkin lymphoma patients
por: Li, Mengyao, et al.
Publicado: (2017)

MiRNAs with prognostic significance in multiple myeloma: A systemic review and meta-analysis
por: Xu, Peipei, et al.
Publicado: (2019)

Efficacy and safety of selinexor in the treatment of AML: A protocol for systematic review and meta-analysis
por: Yu, Liming, et al.
Publicado: (2021)

The Efficacy of Bipolar Sealer on Blood Loss in Primary Total Hip Arthroplasty: A Meta-Analysis
por: Min, Ji-Kang, et al.
Publicado: (2016)

Role of Xingnaojing Injection in treating acute cerebral hemorrhage: A systematic review and meta-analysis
por: Ma, Xiao, et al.
Publicado: (2020)

The role of hydroxyurea to prevent silent stroke in sickle cell disease: Systematic review and meta-analysis
por: Hasson, Carla, et al.
Publicado: (2019)

Association of systemic inflammatory and autoimmune manifestations with myelodysplastic syndromes: A systematic review and meta-analysis
por: Liang, Qian, et al.
Publicado: (2022)

Human leukocyte antigen-DRB1 gene polymorphism and aplastic anemia: A meta-analysis
por: Liang, Lijie, et al.
Publicado: (2023)

Combined immune score predicts the prognosis of newly diagnosed multiple myeloma patients in the bortezomib-based therapy era
por: Wei, Min, et al.
Publicado: (2021)

Clinical value of thyroid related hormones combined with neutrophil to lymphocyte ratio in patients with nonalcoholic fatty liver disease
por: Li, Ping, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rfb7o2ba170r6i1o0gha1hvha1